Patent US4774236A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4774236A Expired / Lapsed US ⏱️ 0.0 years remaining

17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them

Assignee: RTI International
•
Filing: 1986-09-17
•
Granted: 1988-09-27
•
Expires: 2006-09-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Steroids of the formula: <IMAGE> <IMAGE> +TR <IMAGE> which are characterized by a 17 alpha -cyanomethyl, azidomethyl, methoxymethyl, phenylmethyl, or ethynylmethyl substituent and a 17 beta -hydroxy/esterified hydroxy substituent. The steroids of this invention have glucocorticoid, anti-glucocorticoid, progestational, or anti-progestational activity, depending on the particular structure.

Inventors

  • 👤 C. Edgar Cook
  • 👤 C. Ray Tallent
  • 👤 Jerry R. Reel
  • 👤 Mansukh C. Wani

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 13:59
CPC Classifications
C; C07; C07J; C07J41/00; C07J41/0005; C07J41/0016; C07J41/0033; C07J41/0077; C07J41/0083; C07J51/00

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 85 words
A steroid having binding affinity for the glucocorticoid receptor and possessing glucocorticoid activity, selected from the group represented by partial formula (II), wherein Z is selected from partial structures (III) or (IV), ##STR23## wherein: X is selected from the group consisting of --C.tbd.CH, CN, N 3 , SCN, OMe, and Ph; R is acetyl, propionyl or butyryl; R 1 is methyl; R 2 is α-H, β-OH or ═O, with the proviso that when X is CN, R 2 is ═O; and R 3 is H.
Claim 2
Dependent Claim 85 words
A steroid having binding affinity for the glucocorticoid receptor and possessing glucocorticoid activity, selected from the group represented by partial formula (II), wherein Z is selected from partial structures (III) or (IV), ##STR23## wherein: X is selected from the group consisting of --C.tbd.CH, CN, N 3 , SCN, OMe, and Ph; R is acetyl, propionyl or butyryl; R 1 is methyl; R 2 is α-H, β-OH or ═O, with the proviso that when X is CN, R 2 is ═O; and R 3 is H.
Claim 3
Dependent Claim 14 words
A steroid according to claim 1, wherein X is CN, N 3 or OMe.
Claim 4
Dependent Claim 28 words
A method of inducing a glucocorticoid hormonal response, which comprises administering an effective amount of a steroid according to claim 1, to a warm-blooded mammal in need thereof.
Claim 5
Dependent Claim 17 words
The method of claim 3, wherein said warm-blooded mammal is a primate, domestic pet or farm animal.
Claim 6
Dependent Claim 19 words
The method of claim 3, wherein the unit dose of the steroid lies between 0.0001 grams and 1.0 gram.
Claim 7
Dependent Claim 182 words
A steroid having binding affinity for the glucocorticoid receptor and possessing antiglucocorticoid activity, selected from the group represented by partial formula II, wherein Z has partial structure III, ##STR24## wherein: X is selected from the group consisting of N 3 , SCN, and Ph; R is H or C 1 -C 5 acyl; R 1 is methyl or ethyl; R 2 is α-H and an 11β-substituent selected from the group consisting of: (A) --(CH 2 ) n R 5 wherein n≦4 and R 5 =pyridyl, thiazolyl, --NMe 2 , --NEt 2 , ##STR25## OMe; (B) --C 6 H 4 .R 4 wherein R 4 is selected from among the substituents in R 5 or wherein R 4 =--H, --OCH 2 CH 2 NMe 2 , --OCH 2 CH 2 NEt 2 , or --O--(C 1 -C 3 ) alkyl; (C) -halogen, --S--(C 1 -C 3 ) alkyl, --S(O)--(C 1 -C 3 ) alkyl; (D) -S-phenyl, or --S(O)-phenyl; or R 2 is α-H, β-CF 3 ; α-H, β-CHF 2 ; ═CHF; or --CF 2 and R 3 is H or CH 3 .
Claim 8
Dependent Claim 182 words
A steroid having binding affinity for the glucocorticoid receptor and possessing antiglucocorticoid activity, selected from the group represented by partial formula II, wherein Z has partial structure III, ##STR24## wherein: X is selected from the group consisting of N 3 , SCN, and Ph; R is H or C 1 -C 5 acyl; R 1 is methyl or ethyl; R 2 is α-H and an 11β-substituent selected from the group consisting of: (A) --(CH 2 ) n R 5 wherein n≦4 and R 5 =pyridyl, thiazolyl, --NMe 2 , --NEt 2 , ##STR25## OMe; (B) --C 6 H 4 .R 4 wherein R 4 is selected from among the substituents in R 5 or wherein R 4 =--H, --OCH 2 CH 2 NMe 2 , --OCH 2 CH 2 NEt 2 , or --O--(C 1 -C 3 ) alkyl; (C) -halogen, --S--(C 1 -C 3 ) alkyl, --S(O)--(C 1 -C 3 ) alkyl; (D) -S-phenyl, or --S(O)-phenyl; or R 2 is α-H, β-CF 3 ; α-H, β-CHF 2 ; ═CHF; or --CF 2 and R 3 is H or CH 3 .
Claim 9
Dependent Claim 21 words
A steroid according to claim 6, wherein R 2 is α-H and an 11β-substituent selected from the group consisting of: ##STR26##
Claim 10
Dependent Claim 13 words
A steroid according to claim 6, wherein R is acetyl, propionyl or butyryl.
Claim 11
Dependent Claim 27 words
A method of inducing an anti-glucocorticoid antihormonal response, which comprises administering an effective amount of a steroid of claim 6, to a warm-blooded mammal in need thereof.
Claim 12
Dependent Claim 17 words
The method of claim 9, wherein said warm-blooded mammal is a primate, domestic pet or farm animal.
Claim 13
Dependent Claim 19 words
The method of claim 9 wherein the unit dose of the steroid lies between 0.0001 grams and 1.0 gram.
Claim 14
Dependent Claim 175 words
A steroid having binding affinity for the progesterone receptor and possessing antiprogestational activity, selected from the group represented by partial formula II, wherein Z has partial structure III, ##STR27## wherein: X is selected from the group consisting of N 3 ; SCN; and Ph; R is H or lower acyl; R 1 is methyl or ethyl; R 2 is α-H and an 11β-substituent selected from the group consisting of: (A) --(CH 2 ) n R 5 wherein n≦4 and R 5 =pyridyl, thiazolyl, --NMe 2 , --NEt 2 , ##STR28## --OMe; (B) --C 6 H 4 .R 4 wherein R 4 is selected from among the substituents in R 5 or wherein R 4 =--H, --OCH 2 CH 2 NMe 2 , --OCH 2 CH 2 NEt 2 , or --O--(C 1 -C 3 ) alkyl; (C) -halogen, --S--(C 1 -C 3 ) alkyl, --S(O)--(C 1 -C 3 ) alkyl; (D) -S-phenyl, or --S(O)-phenyl; or R 2 is α-H, β-CHF 2 ; ═CHF or ═CF 2 and R 3 is H or CH 3 .
Claim 15
Dependent Claim 175 words
A steroid having binding affinity for the progesterone receptor and possessing antiprogestational activity, selected from the group represented by partial formula II, wherein Z has partial structure III, ##STR27## wherein: X is selected from the group consisting of N 3 ; SCN; and Ph; R is H or lower acyl; R 1 is methyl or ethyl; R 2 is α-H and an 11β-substituent selected from the group consisting of: (A) --(CH 2 ) n R 5 wherein n≦4 and R 5 =pyridyl, thiazolyl, --NMe 2 , --NEt 2 , ##STR28## --OMe; (B) --C 6 H 4 .R 4 wherein R 4 is selected from among the substituents in R 5 or wherein R 4 =--H, --OCH 2 CH 2 NMe 2 , --OCH 2 CH 2 NEt 2 , or --O--(C 1 -C 3 ) alkyl; (C) -halogen, --S--(C 1 -C 3 ) alkyl, --S(O)--(C 1 -C 3 ) alkyl; (D) -S-phenyl, or --S(O)-phenyl; or R 2 is α-H, β-CHF 2 ; ═CHF or ═CF 2 and R 3 is H or CH 3 .
Claim 16
Dependent Claim 21 words
A steroid according to claim 12, wherein R 2 is α-H and an 11β-substituent selected from the group consisting of: ##STR29##
Claim 17
Dependent Claim 13 words
A steroid according to claim 12, wherein R is acetyl, propionyl, or butyryl.
Claim 18
Dependent Claim 27 words
A method of inducing an anti-progestational anti-hormonal response, which comprises administering an effective amount of a steroid of claim 12 to a warm-blooded mammal in need thereof.
Claim 19
Dependent Claim 17 words
The method of claim 15, wherein said warm-blooded mammal is a primate, domestic pet or farm animal.
Claim 20
Dependent Claim 19 words
The method of claim 15, wherein the unit dose of the steroid lies between 0.0001 grams and 1.0 gram.

References Cited (Backward Citations)

US4233296A Cited
US4447424A Cited
US4540686A Cited
US4536401A Cited
EP0192598A2 Cited
DE3506785A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-27 1992-03-28 1992-09-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-27 1996-03-28 1996-09-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-27 2000-03-28 2000-09-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag